<DOC>
	<DOC>NCT02154854</DOC>
	<brief_summary>The purpose of this study is to compare parallel-group effects between 4 months and 12 months post-transplantation 2 values of target residual concentrations of Advagraf on vascular parameters in de novo renal transplant patients.</brief_summary>
	<brief_title>Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Age between 18 et 70 years Patient accepting to give a written informed consent Recipients of a first renal allograft (deceased or living, non HLA identical donor with compatible ABO blood type) Randomized in the ADEQUATE study Patients must have at J112 +/ 3 days a stable renal function (MDRD 4) with an absence of DSA since transplantation. Negative T crossmatch in cytotoxicity Tolerate a daily dose of MMF at 1g Acute rejection during the first months Existence of a BK infection since M3 Proteinuria/reatininuria ratio &gt; 1g/g since M3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Renal</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Arterial stiffness</keyword>
	<keyword>Vascular fibrose plasma markers</keyword>
</DOC>